ArticleAesthetic plastic surgery2026
Preservation of Levator Aponeurosis in Levator Muscle Shortening for Pediatric Myogenic Ptosis: A Retrospective Cohort Study with 1 Year Follow-up.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundPediatric myogenic ptosis has a high incidence, and severe cases significantly impair children's visual function and quality of life. Long-term untreated, it can lead to amblyopia and adverse psychological impacts. Traditional surgical interventions have drawbacks, including high complication rates, relapse, patient discomfort, and unsatisfactory long-term stability, resulting in unmet clinical needs. The Levator Aponeurosis-Preserving Levator Muscle Shortening Procedure (LAPLMSP) is an innovative approach, and this study is the first to explore its application in pediatric patients, aiming to address the challenges of treating this delicate condition in a vulnerable population.
methodsThis retrospective cohort study analyzed 102 pediatric patients (mean age 3.88 years) with severe ptosis. All had a marginal reflex distance 1 (MRD1) < 1 mm and impaired levator function. LAPLMSP was performed under general anesthesia, focusing on preserving the levator aponeurosis while shortening the levator muscle. Postoperative outcomes were monitored at 1 week, 1 month, 6 months, 10 months, and 1 year.
resultsLAPLMSP significantly improved MRD1 from a preoperative mean of 0.40 mm to 5.19 mm at 1 week, 4.54 mm at 1 month , 3.87 mm at 6 months, 2.94 mm at 10 months, and 2.84 mm at 12months (p < 0.001). All caregivers reported high satisfaction with their children's improved functional and aesthetic outcomes. Minor complications, such as over-correction and under-correction, resolved spontaneously without additional interventions.
conclusionsLAPLMSP is a viable and effective treatment for severe pediatric myogenic ptosis, providing substantial functional and aesthetic improvements with high caregiver satisfaction. Its minimally invasive nature, low complication rate, and favorable stability make it a superior option for managing this challenging condition in children. LEVEL OF EVIDENCE II: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
41854903What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.